Malenka Robert C. 4
4 · MapLight Therapeutics, Inc. · Filed Oct 28, 2025
Insider Transaction Report
Form 4
Malenka Robert C.
Director
Transactions
- Award
Employee Stock Option (right to buy)
2025-10-27+139,610→ 139,610 totalExercise: $17.00Exp: 2035-10-26→ Voting Common Stock (139,610 underlying) - Award
Voting Common Stock
2025-10-27+34,390→ 399,671 total - Conversion
Voting Common Stock
2025-10-28+3,895→ 31,672 total(indirect: See footnote) - Conversion
Series C Preferred Stock
2025-10-28−65,477→ 0 total(indirect: See footnote)→ Voting Common Stock (3,895 underlying)
Footnotes (5)
- [F1]Represents a restricted stock unit ("RSU") award. 25% of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
- [F2]Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
- [F3]The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
- [F4]The shares are held by the Robert C. Malenka Living Trust U/A DTD 08/21/2012, of which the Reporting Person is the sole trustee and has voting and dispositive power.
- [F5]1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.